Apex Healthcare Berhad (KLSE:AHEALTH) - Aandelenkoers, Nieuws & Analyse

AHEALTH Overzicht aandelen

AHEALTH fundamentele analyse
Sneeuwvlok Score
Waardering	1/6
Toekomstige groei	2/6
Prestaties in het verleden	2/6
Financiële gezondheid	6/6
Dividenden	5/6

Beloningen

De winst zal naar verwachting met 9.43% per jaar groeien

Risicoanalyse

Winstmarges (9.3%) zijn lager dan vorig jaar (45.5%)

Dividend van 10.12% wordt niet goed gedekt door vrije kasstromen

Apex Healthcare Berhad Concurrenten

Duopharma Biotech Berhad

KLSE:DPHARMA

RM 1.2b

Kotra Industries Berhad

KLSE:KOTRA

RM 642.2m

Y.S.P. Southeast Asia Holding Berhad

KLSE:YSPSAH

RM 322.0m

Rhone Ma Holdings Berhad

KLSE:RHONEMA

RM 149.3m

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor Apex Healthcare Berhad
Historische aandelenkoersen
Huidige aandelenkoers	RM 2.57
52 Week Hoogtepunt	RM 3.42
52 Week Laag	RM 2.38
Bèta	0.31
11 maand verandering	-3.02%
3 maanden verandering	-5.86%
1 Jaar Verandering	5.33%
33 jaar verandering	43.31%
5 jaar verandering	64.04%
Verandering sinds IPO	1,172.59%

Recent nieuws en updates

Recent updates

Why We Think Shareholders May Be Considering Bumping Up Apex Healthcare Berhad's (KLSE:AHEALTH) CEO Compensation

May 08

Apex Healthcare Berhad (KLSE:AHEALTH) Will Pay A Dividend Of MYR0.025

Aug 28

Apex Healthcare Berhad (KLSE:AHEALTH) Has Announced That It Will Be Increasing Its Dividend To RM0.09

Apr 19

Apex Healthcare Berhad (KLSE:AHEALTH) Is Increasing Its Dividend To RM0.09

Feb 25

Apex Healthcare Berhad (KLSE:AHEALTH) Is Paying Out A Larger Dividend Than Last Year

Aug 24

Here's Why Apex Healthcare Berhad (KLSE:AHEALTH) Can Manage Its Debt Responsibly

May 11

Will Weakness in Apex Healthcare Berhad's (KLSE:AHEALTH) Stock Prove Temporary Given Strong Fundamentals?

Feb 11

These 4 Measures Indicate That Apex Healthcare Berhad (KLSE:AHEALTH) Is Using Debt Reasonably Well

Jan 25

Why Apex Healthcare Berhad (KLSE:AHEALTH) Should Be In Your Dividend Portfolio

Jan 07

Do Insiders Own Lots Of Shares In Apex Healthcare Berhad (KLSE:AHEALTH)?

Dec 20

Apex Healthcare Berhad (KLSE:AHEALTH) Has Rewarded Shareholders With An Exceptional 354% Total Return On Their Investment

Dec 05

Why Apex Healthcare Berhad's (KLSE:AHEALTH) CEO Pay Matters

Nov 20

Rendement voor aandeelhouders

	AHEALTH	MY Pharmaceuticals	MY Markt
7D	0.8%	0.2%	0.09%
1Y	5.3%	-0.4%	9.5%

Rendement versus industrie: AHEALTH overtrof de MY Pharmaceuticals industrie, die het afgelopen jaar een rendement -0.4 % opleverde.

Rendement versus markt: AHEALTH presteerde slechter dan MY Market, dat het afgelopen jaar een rendement van 9.5 % opleverde.

Prijsvolatiliteit

Is AHEALTH's price volatile compared to industry and market?
AHEALTH volatility
AHEALTH Average Weekly Movement	1.9%
Pharmaceuticals Industry Average Movement	3.6%
Market Average Movement	5.1%
10% most volatile stocks in MY Market	10.4%
10% least volatile stocks in MY Market	2.5%

Stabiele aandelenkoers: AHEALTH heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.

Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 2% ) van AHEALTH is het afgelopen jaar stabiel geweest.

Over het bedrijf

Opgericht	Werknemers	CEO	Website
1962	976	Kirk Kee	www.apexhealthcare.com.my

Apex Healthcare Berhad, een investeringsholding, houdt zich bezig met de ontwikkeling, productie, marketing, distributie en groothandel van farmaceutische en gezondheidsproducten in Maleisië, Singapore en internationaal. Het bedrijf is actief in drie segmenten: Productie, Distributie en Corporate. Het bedrijf biedt een scala aan producten, waaronder hoestdrank en antihistamine, anti-infectieuze, anti-diabetische, anti-hypertensieve, neuromusculaire, pijnstillende, dermatologische en oogheelkundige producten in de vorm van tabletten, capsules, orale vloeistoffen en suspensies, crèmes en steriele oogdruppels onder de merknaam Xepa.

Apex Healthcare Berhad Samenvatting

Hoe verhouden de winst en inkomsten van Apex Healthcare Berhad zich tot de beurswaarde?
AHEALTH fundamentele statistieken
Marktkapitalisatie	RM 1.85b
Inkomsten(TTM)	RM 89.08m
Inkomsten(TTM)	RM 962.25m

20.8x

Koers/Winstverhouding

1.9x

P/S-verhouding

Is AHEALTH overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
AHEALTH resultatenrekening (TTM)
Inkomsten	RM 962.25m
Kosten van inkomsten	RM 743.36m
Brutowinst	RM 218.90m
Overige uitgaven	RM 129.82m
Inkomsten	RM 89.08m

Laatst gerapporteerde inkomsten

Jun 30, 2024

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)	0.12
Brutomarge	22.75%
Nettowinstmarge	9.26%
Schuld/Eigen Vermogen Verhouding	0.09%

Hoe presteerde AHEALTH op de lange termijn?

Bekijk historische prestaties en vergelijking

Dividenden

10.1%

Huidig dividendrendement

40%

Uitbetalingsratio

AHEALTH Overzicht aandelen

Beloningen

Risicoanalyse

Apex Healthcare Berhad Concurrenten

KLSE:DPHARMA

RM 1.2b

KLSE:KOTRA

RM 642.2m

KLSE:YSPSAH

RM 322.0m

KLSE:RHONEMA

RM 149.3m

Prijsgeschiedenis en prestaties

Recent nieuws en updates

First half dividend increased to RM0.03

Second quarter 2024 earnings released: EPS: RM0.033 (vs RM0.46 in 2Q 2023)

Apex Healthcare Berhad Announces Interim Single-Tier Dividend for the Financial Year Ending 31 December 2024, Payable on September 18, 2024

Apex Healthcare Berhad Appoint Le Wat Su as Independent and Non Executive Member of Nomination Committee

First quarter 2024 earnings released: EPS: RM0.03 (vs RM0.034 in 1Q 2023)

Apex Healthcare Berhad Approves Special Dividend for the Financial Year Ended December 31, 2023

Recent updates

First half dividend increased to RM0.03

Second quarter 2024 earnings released: EPS: RM0.033 (vs RM0.46 in 2Q 2023)

Apex Healthcare Berhad Announces Interim Single-Tier Dividend for the Financial Year Ending 31 December 2024, Payable on September 18, 2024

Apex Healthcare Berhad Appoint Le Wat Su as Independent and Non Executive Member of Nomination Committee

First quarter 2024 earnings released: EPS: RM0.03 (vs RM0.034 in 1Q 2023)

Apex Healthcare Berhad Approves Special Dividend for the Financial Year Ended December 31, 2023

Why We Think Shareholders May Be Considering Bumping Up Apex Healthcare Berhad's (KLSE:AHEALTH) CEO Compensation

Upcoming dividend of RM0.23 per share

Full year 2023 earnings: EPS exceeds analyst expectations

Apex Healthcare Berhad, Annual General Meeting, May 15, 2024

Full year 2023 earnings released: EPS: RM0.56 (vs RM0.14 in FY 2022)

Apex Healthcare Berhad Announces A Special Dividend of the Financial Year Ended 31 December 2023

Apex Healthcare Berhad Announces Promotion of Miss Chiew Woon Wui from Financial Controller to Chief Financial Officer, Effective on January 1, 2024

Apex Healthcare Berhad Announces Promotion of Miss Chiew Woon Wui from Financial Controller to Chief Financial Officer, Effective on January 1, 2024

Third quarter 2023 earnings released: EPS: RM0.034 (vs RM0.038 in 3Q 2022)

Upcoming dividend of RM0.025 per share at 2.5% yield

Price target decreased by 7.3% to RM2.55

Apex Healthcare Berhad (KLSE:AHEALTH) Will Pay A Dividend Of MYR0.025

Apex Healthcare Berhad Provides Earnings Guidance for the Year 2023

Price target decreased by 7.8% to RM2.58

Second quarter 2023 earnings released: EPS: RM0.46 (vs RM0.033 in 2Q 2022)

Investor sentiment deteriorates as stock falls 36%

First quarter 2023 earnings released: EPS: RM0.051 (vs RM0.033 in 1Q 2022)

Upcoming dividend of RM0.055 per share at 2.3% yield

Apex Healthcare Berhad Appoints Yap Seng Chong as Independent and Non-Executive Chairman of Audit Committee, Date of Change 18 May 2023

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Investor sentiment improves as stock rises 15%

Full year 2022 earnings released: EPS: RM0.21 (vs RM0.13 in FY 2021)

Third quarter 2022 earnings released: EPS: RM0.057 (vs RM0.03 in 3Q 2021)

Insufficient new directors

Upcoming dividend of RM0.03 per share

Second quarter 2022 earnings released: EPS: RM0.05 (vs RM0.027 in 2Q 2021)

Apex Healthcare Berhad Declares an Interim Dividend, Payable on 15 September 2022

Price target increased to RM3.21

Upcoming dividend of RM0.09 per share

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

Price target increased to RM3.07

Insufficient new directors

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Apex Healthcare Berhad (KLSE:AHEALTH) Has Announced That It Will Be Increasing Its Dividend To RM0.09

Apex Healthcare Berhad Proposes Special Single-Tier Dividend for Financial Year Ended 31 December 2021, Payable on 16 June 2022

Apex Healthcare Berhad (KLSE:AHEALTH) Is Increasing Its Dividend To RM0.09

Apex Healthcare Berhad Announces Special Dividend in Respect of the Financial Year Ended 31 December2021, Payable on 16 June 2022

Full year 2021 earnings: EPS and revenues miss analyst expectations

Insufficient new directors

Third quarter 2021 earnings released: EPS RM0.03 (vs RM0.03 in 3Q 2020)

Upcoming dividend of RM0.025 per share

Apex Healthcare Berhad (KLSE:AHEALTH) Is Paying Out A Larger Dividend Than Last Year

Second quarter 2021 earnings released: EPS RM0.027 (vs RM0.028 in 2Q 2020)

Upcoming dividend of RM0.028 per share

First quarter 2021 earnings released: EPS RM0.025 (vs RM0.03 in 1Q 2020)

Here's Why Apex Healthcare Berhad (KLSE:AHEALTH) Can Manage Its Debt Responsibly

Full year 2020 earnings released: EPS RM0.12 (vs RM0.11 in FY 2019)

Is Apex Healthcare Berhad (KLSE:AHEALTH) A Smart Pick For Income Investors?

Estimating The Intrinsic Value Of Apex Healthcare Berhad (KLSE:AHEALTH)

Does Apex Healthcare Berhad (KLSE:AHEALTH) Deserve A Spot On Your Watchlist?

Full year 2020 earnings released: EPS RM0.12 (vs RM0.11 in FY 2019)

Revenue and earnings miss expectations

New 90-day low: RM3.32